HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Salvatore Albani Selected Research

Chaperonin 60

10/2012TLR9 agonist CpG enhances protective nasal HSP60 peptide vaccine efficacy in experimental autoimmune arthritis.
12/2011Bystander suppression of experimental arthritis by nasal administration of a heat shock protein peptide.
1/2009Heat shock protein 60 reactive T cells in juvenile idiopathic arthritis: what is new?
6/2006Heat-shock protein 60 as a tool for novel therapeutic strategies that target the induction of regulatory T cells in human arthritis.
7/2005Tolerogenic immune responses to novel T-cell epitopes from heat-shock protein 60 in juvenile idiopathic arthritis.
8/2003Heat shock protein 60 and adjuvant arthritis: a model for T cell regulation in human arthritis.
7/2002Inhibition of adjuvant-induced arthritis by interleukin-10-driven regulatory cells induced via nasal administration of a peptide analog of an arthritis-related heat-shock protein 60 T cell epitope.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Salvatore Albani Research Topics

Disease

21Inflammation (Inflammations)
01/2020 - 01/2002
10Juvenile Arthritis (Juvenile Idiopathic Arthritis)
02/2017 - 10/2002
10Rheumatoid Arthritis
11/2013 - 03/2004
9Arthritis (Polyarthritis)
10/2012 - 01/2002
6Autoimmune Diseases (Autoimmune Disease)
01/2015 - 10/2002
6Experimental Arthritis
10/2012 - 01/2002
4Neoplasms (Cancer)
11/2022 - 01/2017
3Rheumatic Diseases (Rheumatism)
11/2022 - 09/2005
3Fibrosis (Cirrhosis)
12/2021 - 01/2019
2Drug Resistant Epilepsy
01/2022 - 01/2019
2Hepatocellular Carcinoma (Hepatoma)
01/2022 - 01/2019
2Dermatomyositis (Dermatopolymyositis)
09/2005 - 11/2002
1Hypoxia (Hypoxemia)
11/2022
1Drug-Related Side Effects and Adverse Reactions
01/2022
1Systemic Scleroderma (Systemic Sclerosis)
12/2021
1Non-Muscle Invasive Bladder Neoplasms
01/2020
1Lung Diseases (Lung Disease)
01/2020
1Non-alcoholic Fatty Liver Disease
01/2019
1Seizures (Absence Seizure)
01/2019
1Fatty Liver
01/2019
1Disease Progression
01/2019
1Hyperglycemia
01/2019
1Liver Cirrhosis (Hepatic Cirrhosis)
01/2019
1Macrophage Activation Syndrome
11/2018
1Lymphopenia (Lymphocytopenia)
11/2017
1Necrosis
01/2017
1Dry Eye Syndromes (Dry Eye Syndrome)
09/2014
1Infections
03/2013
1Atherosclerosis
11/2012
1Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
11/2012
1Thrombosis (Thrombus)
11/2012
1Hypertension (High Blood Pressure)
11/2012
1Multiple Sclerosis
11/2012
1Pediatric Crohn's disease
11/2009
1Crohn Disease (Crohn's Disease)
11/2009
1Ankylosing Spondylitis
05/2009

Drug/Important Bio-Agent (IBA)

14EpitopesIBA
11/2012 - 07/2002
11Peptides (Polypeptides)IBA
11/2012 - 07/2002
10AntigensIBA
02/2017 - 07/2002
7Chaperonin 60IBA
10/2012 - 07/2002
7Heat-Shock Proteins (Heat-Shock Protein)IBA
12/2011 - 12/2002
6CytokinesIBA
01/2019 - 07/2002
5T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
11/2009 - 07/2002
5Proteins (Proteins, Gene)FDA Link
05/2009 - 10/2002
4Interleukin-10 (Interleukin 10)IBA
10/2012 - 07/2002
3LigandsIBA
11/2022 - 01/2002
3ChemokinesIBA
11/2022 - 11/2006
3Interleukin-11 (Interleukin 11)IBA
12/2021 - 01/2019
3Biological ProductsIBA
05/2011 - 02/2007
2Neutralizing AntibodiesIBA
11/2022 - 01/2019
2AntibodiesIBA
01/2019 - 07/2002
2Toll-Like Receptors (Toll-Like Receptor)IBA
01/2017 - 09/2014
2Tumor Necrosis Factor InhibitorsIBA
05/2009 - 09/2006
2Myosins (Myosin)IBA
09/2005 - 11/2002
2DNA (Deoxyribonucleic Acid)IBA
09/2005 - 01/2002
2Interferon-gamma (Interferon, gamma)IBA
07/2005 - 08/2004
1mRNA VaccinesIBA
11/2022
1Messenger RNA (mRNA)IBA
11/2022
1HLA Antigens (Human Leukocyte Antigens)IBA
11/2022
1Granzymes (Granzyme)IBA
11/2022
1Immune Checkpoint InhibitorsIBA
01/2022
1Anticonvulsants (Antiepileptic Drugs)IBA
01/2022
1CD40 Ligand (CD40L)IBA
10/2021
1Tryptophan (L-Tryptophan)FDA Link
10/2021
1InterferonsIBA
10/2021
1Bleomycin (Blenoxane)FDA LinkGeneric
01/2020
1NF-kappa B (NF-kB)IBA
01/2020
1RNA (Ribonucleic Acid)IBA
01/2020
1Interleukin-11 Receptors (Interleukin 11 Receptor)IBA
01/2019
1FructoseIBA
01/2019
1Methionine (L-Methionine)FDA Link
01/2019
1Choline (Choline Chloride)IBA
01/2019
1Yttrium-90IBA
01/2019
1Interleukin-17 (Interleukin 17)IBA
01/2019
1MicroRNAs (MicroRNA)IBA
11/2018
1AutoantigensIBA
11/2017
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
02/2017
1Tacrolimus (Prograf)FDA LinkGeneric
09/2014
1Cyclosporine (Ciclosporin)FDA LinkGeneric
09/2014
1Adrenal Cortex Hormones (Corticosteroids)IBA
09/2014
1Lymphotoxin-alpha (Lymphotoxin)IBA
11/2013
1Glatiramer Acetate (Copaxone)FDA Link
11/2012
1Environmental Pollutants (Pollutants, Environmental)IBA
11/2012
1Protein Subunit VaccinesIBA
10/2012
1Phosphates (Orthophosphate)IBA
12/2011
1Freund's AdjuvantIBA
12/2011
1Interleukin-6 (Interleukin 6)IBA
06/2011
1Interleukin-1 (Interleukin 1)IBA
06/2011
1Pharmaceutical PreparationsIBA
11/2009
1Antirheumatic Agents (DMARD)IBA
05/2009

Therapy/Procedure

13Therapeutics
01/2019 - 12/2002
11Immunotherapy
01/2022 - 03/2004
3Intranasal Administration
12/2011 - 07/2002
1Drug Therapy (Chemotherapy)
01/2022
1Injections
01/2019
1Ligation
01/2017
1Cell- and Tissue-Based Therapy (Cell Therapy)
01/2015
1Stem Cell Transplantation
03/2013
1Mucosal Administration
12/2011
1Immunomodulation
09/2010